Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review
Authors:
Top Cited Papers
Open Access
- 22 January 2024
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-12
Abstract
This comprehensive review delves into cancer’s complexity, focusing on adhesion, metastasis, and inhibition. It explores the pivotal role of these factors in disease progression and therapeutic strategies. This review covers cancer cell migration, invasion, and colonization of distant organs, emphasizing the significance of cell adhesion and the intricate metastasis process. Inhibition approaches targeting adhesion molecules, such as integrins and cadherins, are discussed. Overall, this review contributes significantly to advancing cancer research and developing targeted therapies, holding promise for improving patient outcomes worldwide. Exploring different inhibition strategies revealed promising therapeutic targets to alleviate adhesion and metastasis of cancer cells. The effectiveness of integrin-blocking antibodies, small molecule inhibitors targeting Focal adhesion kinase (FAK) and the Transforming Growth Factor β (TGF-β) pathway, and combination therapies underscores their potential to disrupt focal adhesions and control epithelial-mesenchymal transition processes. The identification of as FAK, Src, β-catenin and SMAD4 offers valuable starting points for further research and the development of targeted therapies. The complex interrelationships between adhesion and metastatic signaling networks will be relevant to the development of new treatment approaches.Keywords
Funding Information
- Private Universität Witten/Herdecke gGmbH
This publication has 82 references indexed in Scilit:
- Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testingExpert Review of Molecular Diagnostics, 2012
- Personalized Medicine and CancerJournal of Personalized Medicine, 2012
- Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancerMolecular Biology of the Cell, 2011
- Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionNature Medicine, 2011
- Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forcesJournal of Cell Science, 2011
- Integrin Targeted TherapeuticsTheranostics, 2011
- Epithelial–Mesenchymal Transition in Hepatocellular CarcinomaFuture Oncology, 2009
- Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrinOncogene, 2009
- Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit AllJournal of Biopharmaceutical Statistics, 2009
- TGF-β and the Smad Signaling Pathway Support Transcriptomic Reprogramming during Epithelial-Mesenchymal Cell TransitionMolecular Biology of the Cell, 2005